Global Rosuvastatin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Rosuvastatin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.
United States market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Rosuvastatin players cover AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Rosuvastatin Industry Forecast” looks at past sales and reviews total world Rosuvastatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Rosuvastatin sales for 2025 through 2031. With Rosuvastatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin industry.
This Insight Report provides a comprehensive analysis of the global Rosuvastatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rosuvastatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Rosuvastatin market?
What factors are driving Rosuvastatin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin market opportunities vary by end market size?
How does Rosuvastatin break out by Type, by Application?
The global Rosuvastatin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.
United States market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Rosuvastatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Rosuvastatin players cover AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Rosuvastatin Industry Forecast” looks at past sales and reviews total world Rosuvastatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Rosuvastatin sales for 2025 through 2031. With Rosuvastatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin industry.
This Insight Report provides a comprehensive analysis of the global Rosuvastatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rosuvastatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity 98.0%
- Purity 99.0%
- Other
- Tablet
- Capsule
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
What is the 10-year outlook for the global Rosuvastatin market?
What factors are driving Rosuvastatin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin market opportunities vary by end market size?
How does Rosuvastatin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rosuvastatin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rosuvastatin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rosuvastatin by Country/Region, 2020, 2024 & 2031
2.2 Rosuvastatin Segment by Type
2.2.1 Purity 98.0%
2.2.2 Purity 99.0%
2.2.3 Other
2.3 Rosuvastatin Sales by Type
2.3.1 Global Rosuvastatin Sales Market Share by Type (2020-2025)
2.3.2 Global Rosuvastatin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rosuvastatin Sale Price by Type (2020-2025)
2.4 Rosuvastatin Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Others
2.5 Rosuvastatin Sales by Application
2.5.1 Global Rosuvastatin Sale Market Share by Application (2020-2025)
2.5.2 Global Rosuvastatin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rosuvastatin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rosuvastatin Breakdown Data by Company
3.1.1 Global Rosuvastatin Annual Sales by Company (2020-2025)
3.1.2 Global Rosuvastatin Sales Market Share by Company (2020-2025)
3.2 Global Rosuvastatin Annual Revenue by Company (2020-2025)
3.2.1 Global Rosuvastatin Revenue by Company (2020-2025)
3.2.2 Global Rosuvastatin Revenue Market Share by Company (2020-2025)
3.3 Global Rosuvastatin Sale Price by Company
3.4 Key Manufacturers Rosuvastatin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rosuvastatin Product Location Distribution
3.4.2 Players Rosuvastatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROSUVASTATIN BY GEOGRAPHIC REGION
4.1 World Historic Rosuvastatin Market Size by Geographic Region (2020-2025)
4.1.1 Global Rosuvastatin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rosuvastatin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rosuvastatin Market Size by Country/Region (2020-2025)
4.2.1 Global Rosuvastatin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rosuvastatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rosuvastatin Sales Growth
4.4 APAC Rosuvastatin Sales Growth
4.5 Europe Rosuvastatin Sales Growth
4.6 Middle East & Africa Rosuvastatin Sales Growth
5 AMERICAS
5.1 Americas Rosuvastatin Sales by Country
5.1.1 Americas Rosuvastatin Sales by Country (2020-2025)
5.1.2 Americas Rosuvastatin Revenue by Country (2020-2025)
5.2 Americas Rosuvastatin Sales by Type (2020-2025)
5.3 Americas Rosuvastatin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rosuvastatin Sales by Region
6.1.1 APAC Rosuvastatin Sales by Region (2020-2025)
6.1.2 APAC Rosuvastatin Revenue by Region (2020-2025)
6.2 APAC Rosuvastatin Sales by Type (2020-2025)
6.3 APAC Rosuvastatin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rosuvastatin by Country
7.1.1 Europe Rosuvastatin Sales by Country (2020-2025)
7.1.2 Europe Rosuvastatin Revenue by Country (2020-2025)
7.2 Europe Rosuvastatin Sales by Type (2020-2025)
7.3 Europe Rosuvastatin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rosuvastatin by Country
8.1.1 Middle East & Africa Rosuvastatin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rosuvastatin Revenue by Country (2020-2025)
8.2 Middle East & Africa Rosuvastatin Sales by Type (2020-2025)
8.3 Middle East & Africa Rosuvastatin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rosuvastatin
10.3 Manufacturing Process Analysis of Rosuvastatin
10.4 Industry Chain Structure of Rosuvastatin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rosuvastatin Distributors
11.3 Rosuvastatin Customer
12 WORLD FORECAST REVIEW FOR ROSUVASTATIN BY GEOGRAPHIC REGION
12.1 Global Rosuvastatin Market Size Forecast by Region
12.1.1 Global Rosuvastatin Forecast by Region (2026-2031)
12.1.2 Global Rosuvastatin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rosuvastatin Forecast by Type (2026-2031)
12.7 Global Rosuvastatin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Rosuvastatin Product Portfolios and Specifications
13.1.3 AstraZeneca Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Information
13.2.2 Teva Pharmaceutical Industries Rosuvastatin Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Industries Main Business Overview
13.2.5 Teva Pharmaceutical Industries Latest Developments
13.3 MSN Laboratories
13.3.1 MSN Laboratories Company Information
13.3.2 MSN Laboratories Rosuvastatin Product Portfolios and Specifications
13.3.3 MSN Laboratories Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSN Laboratories Main Business Overview
13.3.5 MSN Laboratories Latest Developments
13.4 Cadila Pharmaceuticals
13.4.1 Cadila Pharmaceuticals Company Information
13.4.2 Cadila Pharmaceuticals Rosuvastatin Product Portfolios and Specifications
13.4.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cadila Pharmaceuticals Main Business Overview
13.4.5 Cadila Pharmaceuticals Latest Developments
13.5 LGM Pharma
13.5.1 LGM Pharma Company Information
13.5.2 LGM Pharma Rosuvastatin Product Portfolios and Specifications
13.5.3 LGM Pharma Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 LGM Pharma Main Business Overview
13.5.5 LGM Pharma Latest Developments
13.6 Bal Pharma
13.6.1 Bal Pharma Company Information
13.6.2 Bal Pharma Rosuvastatin Product Portfolios and Specifications
13.6.3 Bal Pharma Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bal Pharma Main Business Overview
13.6.5 Bal Pharma Latest Developments
13.7 Changzhou Pharmaceutical Factory
13.7.1 Changzhou Pharmaceutical Factory Company Information
13.7.2 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolios and Specifications
13.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changzhou Pharmaceutical Factory Main Business Overview
13.7.5 Changzhou Pharmaceutical Factory Latest Developments
13.8 Jingxin Pharm
13.8.1 Jingxin Pharm Company Information
13.8.2 Jingxin Pharm Rosuvastatin Product Portfolios and Specifications
13.8.3 Jingxin Pharm Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Jingxin Pharm Main Business Overview
13.8.5 Jingxin Pharm Latest Developments
13.9 Zhejiang Hisun Pharmaceutical
13.9.1 Zhejiang Hisun Pharmaceutical Company Information
13.9.2 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhejiang Hisun Pharmaceutical Main Business Overview
13.9.5 Zhejiang Hisun Pharmaceutical Latest Developments
13.10 HEC Pharm
13.10.1 HEC Pharm Company Information
13.10.2 HEC Pharm Rosuvastatin Product Portfolios and Specifications
13.10.3 HEC Pharm Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HEC Pharm Main Business Overview
13.10.5 HEC Pharm Latest Developments
13.11 Lunan Pharmaceutical
13.11.1 Lunan Pharmaceutical Company Information
13.11.2 Lunan Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.11.3 Lunan Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lunan Pharmaceutical Main Business Overview
13.11.5 Lunan Pharmaceutical Latest Developments
13.12 Nanjing Frochem Tech
13.12.1 Nanjing Frochem Tech Company Information
13.12.2 Nanjing Frochem Tech Rosuvastatin Product Portfolios and Specifications
13.12.3 Nanjing Frochem Tech Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Nanjing Frochem Tech Main Business Overview
13.12.5 Nanjing Frochem Tech Latest Developments
13.13 Lianyungang Runzhong Pharmaceutical
13.13.1 Lianyungang Runzhong Pharmaceutical Company Information
13.13.2 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.13.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.14 Shandong Bechem Chemicals
13.14.1 Shandong Bechem Chemicals Company Information
13.14.2 Shandong Bechem Chemicals Rosuvastatin Product Portfolios and Specifications
13.14.3 Shandong Bechem Chemicals Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Shandong Bechem Chemicals Main Business Overview
13.14.5 Shandong Bechem Chemicals Latest Developments
13.15 CTX Life Sciences
13.15.1 CTX Life Sciences Company Information
13.15.2 CTX Life Sciences Rosuvastatin Product Portfolios and Specifications
13.15.3 CTX Life Sciences Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CTX Life Sciences Main Business Overview
13.15.5 CTX Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Rosuvastatin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rosuvastatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity 98.0%
Table 4. Major Players of Purity 99.0%
Table 5. Major Players of Other
Table 6. Global Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 7. Global Rosuvastatin Sales Market Share byType (2020-2025)
Table 8. Global Rosuvastatin Revenue byType (2020-2025) & ($ million)
Table 9. Global Rosuvastatin Revenue Market Share byType (2020-2025)
Table 10. Global Rosuvastatin Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Rosuvastatin Sale by Application (2020-2025) & (K MT)
Table 12. Global Rosuvastatin Sale Market Share by Application (2020-2025)
Table 13. Global Rosuvastatin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Rosuvastatin Revenue Market Share by Application (2020-2025)
Table 15. Global Rosuvastatin Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Rosuvastatin Sales by Company (2020-2025) & (K MT)
Table 17. Global Rosuvastatin Sales Market Share by Company (2020-2025)
Table 18. Global Rosuvastatin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Rosuvastatin Revenue Market Share by Company (2020-2025)
Table 20. Global Rosuvastatin Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Rosuvastatin Producing Area Distribution and Sales Area
Table 22. Players Rosuvastatin Products Offered
Table 23. Rosuvastatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Rosuvastatin Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Rosuvastatin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Rosuvastatin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Rosuvastatin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Rosuvastatin Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Rosuvastatin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Rosuvastatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Rosuvastatin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 35. Americas Rosuvastatin Sales Market Share by Country (2020-2025)
Table 36. Americas Rosuvastatin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 38. Americas Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 39. APAC Rosuvastatin Sales by Region (2020-2025) & (K MT)
Table 40. APAC Rosuvastatin Sales Market Share by Region (2020-2025)
Table 41. APAC Rosuvastatin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 43. APAC Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 44. Europe Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 45. Europe Rosuvastatin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 47. Europe Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Rosuvastatin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 51. Middle East & Africa Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Rosuvastatin
Table 53. Key Market Challenges & Risks of Rosuvastatin
Table 54. Key IndustryTrends of Rosuvastatin
Table 55. Rosuvastatin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Rosuvastatin Distributors List
Table 58. Rosuvastatin Customer List
Table 59. Global Rosuvastatin SalesForecast by Region (2026-2031) & (K MT)
Table 60. Global Rosuvastatin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 62. Americas Rosuvastatin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Rosuvastatin SalesForecast by Region (2026-2031) & (K MT)
Table 64. APAC Rosuvastatin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 66. Europe Rosuvastatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Rosuvastatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Rosuvastatin SalesForecast byType (2026-2031) & (K MT)
Table 70. Global Rosuvastatin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Rosuvastatin SalesForecast by Application (2026-2031) & (K MT)
Table 72. Global Rosuvastatin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. AstraZeneca Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Rosuvastatin Product Portfolios and Specifications
Table 75. AstraZeneca Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78.Teva Pharmaceutical Industries Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 79.Teva Pharmaceutical Industries Rosuvastatin Product Portfolios and Specifications
Table 80.Teva Pharmaceutical Industries Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81.Teva Pharmaceutical Industries Main Business
Table 82.Teva Pharmaceutical Industries Latest Developments
Table 83. MSN Laboratories Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 84. MSN Laboratories Rosuvastatin Product Portfolios and Specifications
Table 85. MSN Laboratories Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. MSN Laboratories Main Business
Table 87. MSN Laboratories Latest Developments
Table 88. Cadila Pharmaceuticals Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Pharmaceuticals Rosuvastatin Product Portfolios and Specifications
Table 90. Cadila Pharmaceuticals Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Cadila Pharmaceuticals Main Business
Table 92. Cadila Pharmaceuticals Latest Developments
Table 93. LGM Pharma Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 94. LGM Pharma Rosuvastatin Product Portfolios and Specifications
Table 95. LGM Pharma Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. LGM Pharma Main Business
Table 97. LGM Pharma Latest Developments
Table 98. Bal Pharma Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 99. Bal Pharma Rosuvastatin Product Portfolios and Specifications
Table 100. Bal Pharma Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bal Pharma Main Business
Table 102. Bal Pharma Latest Developments
Table 103. Changzhou PharmaceuticalFactory Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 104. Changzhou PharmaceuticalFactory Rosuvastatin Product Portfolios and Specifications
Table 105. Changzhou PharmaceuticalFactory Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Changzhou PharmaceuticalFactory Main Business
Table 107. Changzhou PharmaceuticalFactory Latest Developments
Table 108. Jingxin Pharm Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 109. Jingxin Pharm Rosuvastatin Product Portfolios and Specifications
Table 110. Jingxin Pharm Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Jingxin Pharm Main Business
Table 112. Jingxin Pharm Latest Developments
Table 113. Zhejiang Hisun Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 115. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zhejiang Hisun Pharmaceutical Main Business
Table 117. Zhejiang Hisun Pharmaceutical Latest Developments
Table 118. HEC Pharm Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 119. HEC Pharm Rosuvastatin Product Portfolios and Specifications
Table 120. HEC Pharm Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. HEC Pharm Main Business
Table 122. HEC Pharm Latest Developments
Table 123. Lunan Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 124. Lunan Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 125. Lunan Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Lunan Pharmaceutical Main Business
Table 127. Lunan Pharmaceutical Latest Developments
Table 128. NanjingFrochemTech Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 129. NanjingFrochemTech Rosuvastatin Product Portfolios and Specifications
Table 130. NanjingFrochemTech Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. NanjingFrochemTech Main Business
Table 132. NanjingFrochemTech Latest Developments
Table 133. Lianyungang Runzhong Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 134. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 135. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Lianyungang Runzhong Pharmaceutical Main Business
Table 137. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 138. Shandong Bechem Chemicals Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Bechem Chemicals Rosuvastatin Product Portfolios and Specifications
Table 140. Shandong Bechem Chemicals Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Shandong Bechem Chemicals Main Business
Table 142. Shandong Bechem Chemicals Latest Developments
Table 143. CTX Life Sciences Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 144. CTX Life Sciences Rosuvastatin Product Portfolios and Specifications
Table 145. CTX Life Sciences Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. CTX Life Sciences Main Business
Table 147. CTX Life Sciences Latest Developments
LIST OFFIGURES
Figure 1. Picture of Rosuvastatin
Figure 2. Rosuvastatin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rosuvastatin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Rosuvastatin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rosuvastatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rosuvastatin Sales Market Share by Country/Region (2024)
Figure 10. Rosuvastatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity 98.0%
Figure 12. Product Picture of Purity 99.0%
Figure 13. Product Picture of Other
Figure 14. Global Rosuvastatin Sales Market Share byType in 2025
Figure 15. Global Rosuvastatin Revenue Market Share byType (2020-2025)
Figure 16. Rosuvastatin Consumed inTablet
Figure 17. Global Rosuvastatin Market:Tablet (2020-2025) & (K MT)
Figure 18. Rosuvastatin Consumed in Capsule
Figure 19. Global Rosuvastatin Market: Capsule (2020-2025) & (K MT)
Figure 20. Rosuvastatin Consumed in Others
Figure 21. Global Rosuvastatin Market: Others (2020-2025) & (K MT)
Figure 22. Global Rosuvastatin Sale Market Share by Application (2024)
Figure 23. Global Rosuvastatin Revenue Market Share by Application in 2025
Figure 24. Rosuvastatin Sales by Company in 2025 (K MT)
Figure 25. Global Rosuvastatin Sales Market Share by Company in 2025
Figure 26. Rosuvastatin Revenue by Company in 2025 ($ millions)
Figure 27. Global Rosuvastatin Revenue Market Share by Company in 2025
Figure 28. Global Rosuvastatin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Rosuvastatin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Rosuvastatin Sales 2020-2025 (K MT)
Figure 31. Americas Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 32. APAC Rosuvastatin Sales 2020-2025 (K MT)
Figure 33. APAC Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 34. Europe Rosuvastatin Sales 2020-2025 (K MT)
Figure 35. Europe Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Rosuvastatin Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 38. Americas Rosuvastatin Sales Market Share by Country in 2025
Figure 39. Americas Rosuvastatin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Rosuvastatin Sales Market Share byType (2020-2025)
Figure 41. Americas Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 42. United States Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Rosuvastatin Sales Market Share by Region in 2025
Figure 47. APAC Rosuvastatin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Rosuvastatin Sales Market Share byType (2020-2025)
Figure 49. APAC Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 50. China Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Rosuvastatin Sales Market Share by Country in 2025
Figure 58. Europe Rosuvastatin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Rosuvastatin Sales Market Share byType (2020-2025)
Figure 60. Europe Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 61. Germany Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 62.France Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Rosuvastatin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Rosuvastatin Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Rosuvastatin in 2025
Figure 75. Manufacturing Process Analysis of Rosuvastatin
Figure 76. Industry Chain Structure of Rosuvastatin
Figure 77. Channels of Distribution
Figure 78. Global Rosuvastatin Sales MarketForecast by Region (2026-2031)
Figure 79. Global Rosuvastatin Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Rosuvastatin Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Rosuvastatin Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Rosuvastatin Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Rosuvastatin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rosuvastatin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rosuvastatin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rosuvastatin by Country/Region, 2020, 2024 & 2031
2.2 Rosuvastatin Segment by Type
2.2.1 Purity 98.0%
2.2.2 Purity 99.0%
2.2.3 Other
2.3 Rosuvastatin Sales by Type
2.3.1 Global Rosuvastatin Sales Market Share by Type (2020-2025)
2.3.2 Global Rosuvastatin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rosuvastatin Sale Price by Type (2020-2025)
2.4 Rosuvastatin Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Others
2.5 Rosuvastatin Sales by Application
2.5.1 Global Rosuvastatin Sale Market Share by Application (2020-2025)
2.5.2 Global Rosuvastatin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rosuvastatin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rosuvastatin Breakdown Data by Company
3.1.1 Global Rosuvastatin Annual Sales by Company (2020-2025)
3.1.2 Global Rosuvastatin Sales Market Share by Company (2020-2025)
3.2 Global Rosuvastatin Annual Revenue by Company (2020-2025)
3.2.1 Global Rosuvastatin Revenue by Company (2020-2025)
3.2.2 Global Rosuvastatin Revenue Market Share by Company (2020-2025)
3.3 Global Rosuvastatin Sale Price by Company
3.4 Key Manufacturers Rosuvastatin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rosuvastatin Product Location Distribution
3.4.2 Players Rosuvastatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROSUVASTATIN BY GEOGRAPHIC REGION
4.1 World Historic Rosuvastatin Market Size by Geographic Region (2020-2025)
4.1.1 Global Rosuvastatin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rosuvastatin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rosuvastatin Market Size by Country/Region (2020-2025)
4.2.1 Global Rosuvastatin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rosuvastatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rosuvastatin Sales Growth
4.4 APAC Rosuvastatin Sales Growth
4.5 Europe Rosuvastatin Sales Growth
4.6 Middle East & Africa Rosuvastatin Sales Growth
5 AMERICAS
5.1 Americas Rosuvastatin Sales by Country
5.1.1 Americas Rosuvastatin Sales by Country (2020-2025)
5.1.2 Americas Rosuvastatin Revenue by Country (2020-2025)
5.2 Americas Rosuvastatin Sales by Type (2020-2025)
5.3 Americas Rosuvastatin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rosuvastatin Sales by Region
6.1.1 APAC Rosuvastatin Sales by Region (2020-2025)
6.1.2 APAC Rosuvastatin Revenue by Region (2020-2025)
6.2 APAC Rosuvastatin Sales by Type (2020-2025)
6.3 APAC Rosuvastatin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rosuvastatin by Country
7.1.1 Europe Rosuvastatin Sales by Country (2020-2025)
7.1.2 Europe Rosuvastatin Revenue by Country (2020-2025)
7.2 Europe Rosuvastatin Sales by Type (2020-2025)
7.3 Europe Rosuvastatin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rosuvastatin by Country
8.1.1 Middle East & Africa Rosuvastatin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rosuvastatin Revenue by Country (2020-2025)
8.2 Middle East & Africa Rosuvastatin Sales by Type (2020-2025)
8.3 Middle East & Africa Rosuvastatin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rosuvastatin
10.3 Manufacturing Process Analysis of Rosuvastatin
10.4 Industry Chain Structure of Rosuvastatin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rosuvastatin Distributors
11.3 Rosuvastatin Customer
12 WORLD FORECAST REVIEW FOR ROSUVASTATIN BY GEOGRAPHIC REGION
12.1 Global Rosuvastatin Market Size Forecast by Region
12.1.1 Global Rosuvastatin Forecast by Region (2026-2031)
12.1.2 Global Rosuvastatin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rosuvastatin Forecast by Type (2026-2031)
12.7 Global Rosuvastatin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Rosuvastatin Product Portfolios and Specifications
13.1.3 AstraZeneca Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Information
13.2.2 Teva Pharmaceutical Industries Rosuvastatin Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Industries Main Business Overview
13.2.5 Teva Pharmaceutical Industries Latest Developments
13.3 MSN Laboratories
13.3.1 MSN Laboratories Company Information
13.3.2 MSN Laboratories Rosuvastatin Product Portfolios and Specifications
13.3.3 MSN Laboratories Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSN Laboratories Main Business Overview
13.3.5 MSN Laboratories Latest Developments
13.4 Cadila Pharmaceuticals
13.4.1 Cadila Pharmaceuticals Company Information
13.4.2 Cadila Pharmaceuticals Rosuvastatin Product Portfolios and Specifications
13.4.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cadila Pharmaceuticals Main Business Overview
13.4.5 Cadila Pharmaceuticals Latest Developments
13.5 LGM Pharma
13.5.1 LGM Pharma Company Information
13.5.2 LGM Pharma Rosuvastatin Product Portfolios and Specifications
13.5.3 LGM Pharma Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 LGM Pharma Main Business Overview
13.5.5 LGM Pharma Latest Developments
13.6 Bal Pharma
13.6.1 Bal Pharma Company Information
13.6.2 Bal Pharma Rosuvastatin Product Portfolios and Specifications
13.6.3 Bal Pharma Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bal Pharma Main Business Overview
13.6.5 Bal Pharma Latest Developments
13.7 Changzhou Pharmaceutical Factory
13.7.1 Changzhou Pharmaceutical Factory Company Information
13.7.2 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolios and Specifications
13.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changzhou Pharmaceutical Factory Main Business Overview
13.7.5 Changzhou Pharmaceutical Factory Latest Developments
13.8 Jingxin Pharm
13.8.1 Jingxin Pharm Company Information
13.8.2 Jingxin Pharm Rosuvastatin Product Portfolios and Specifications
13.8.3 Jingxin Pharm Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Jingxin Pharm Main Business Overview
13.8.5 Jingxin Pharm Latest Developments
13.9 Zhejiang Hisun Pharmaceutical
13.9.1 Zhejiang Hisun Pharmaceutical Company Information
13.9.2 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhejiang Hisun Pharmaceutical Main Business Overview
13.9.5 Zhejiang Hisun Pharmaceutical Latest Developments
13.10 HEC Pharm
13.10.1 HEC Pharm Company Information
13.10.2 HEC Pharm Rosuvastatin Product Portfolios and Specifications
13.10.3 HEC Pharm Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HEC Pharm Main Business Overview
13.10.5 HEC Pharm Latest Developments
13.11 Lunan Pharmaceutical
13.11.1 Lunan Pharmaceutical Company Information
13.11.2 Lunan Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.11.3 Lunan Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lunan Pharmaceutical Main Business Overview
13.11.5 Lunan Pharmaceutical Latest Developments
13.12 Nanjing Frochem Tech
13.12.1 Nanjing Frochem Tech Company Information
13.12.2 Nanjing Frochem Tech Rosuvastatin Product Portfolios and Specifications
13.12.3 Nanjing Frochem Tech Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Nanjing Frochem Tech Main Business Overview
13.12.5 Nanjing Frochem Tech Latest Developments
13.13 Lianyungang Runzhong Pharmaceutical
13.13.1 Lianyungang Runzhong Pharmaceutical Company Information
13.13.2 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolios and Specifications
13.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.13.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.14 Shandong Bechem Chemicals
13.14.1 Shandong Bechem Chemicals Company Information
13.14.2 Shandong Bechem Chemicals Rosuvastatin Product Portfolios and Specifications
13.14.3 Shandong Bechem Chemicals Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Shandong Bechem Chemicals Main Business Overview
13.14.5 Shandong Bechem Chemicals Latest Developments
13.15 CTX Life Sciences
13.15.1 CTX Life Sciences Company Information
13.15.2 CTX Life Sciences Rosuvastatin Product Portfolios and Specifications
13.15.3 CTX Life Sciences Rosuvastatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 CTX Life Sciences Main Business Overview
13.15.5 CTX Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Rosuvastatin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rosuvastatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity 98.0%
Table 4. Major Players of Purity 99.0%
Table 5. Major Players of Other
Table 6. Global Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 7. Global Rosuvastatin Sales Market Share byType (2020-2025)
Table 8. Global Rosuvastatin Revenue byType (2020-2025) & ($ million)
Table 9. Global Rosuvastatin Revenue Market Share byType (2020-2025)
Table 10. Global Rosuvastatin Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Rosuvastatin Sale by Application (2020-2025) & (K MT)
Table 12. Global Rosuvastatin Sale Market Share by Application (2020-2025)
Table 13. Global Rosuvastatin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Rosuvastatin Revenue Market Share by Application (2020-2025)
Table 15. Global Rosuvastatin Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Rosuvastatin Sales by Company (2020-2025) & (K MT)
Table 17. Global Rosuvastatin Sales Market Share by Company (2020-2025)
Table 18. Global Rosuvastatin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Rosuvastatin Revenue Market Share by Company (2020-2025)
Table 20. Global Rosuvastatin Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Rosuvastatin Producing Area Distribution and Sales Area
Table 22. Players Rosuvastatin Products Offered
Table 23. Rosuvastatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Rosuvastatin Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Rosuvastatin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Rosuvastatin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Rosuvastatin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Rosuvastatin Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Rosuvastatin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Rosuvastatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Rosuvastatin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 35. Americas Rosuvastatin Sales Market Share by Country (2020-2025)
Table 36. Americas Rosuvastatin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 38. Americas Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 39. APAC Rosuvastatin Sales by Region (2020-2025) & (K MT)
Table 40. APAC Rosuvastatin Sales Market Share by Region (2020-2025)
Table 41. APAC Rosuvastatin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 43. APAC Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 44. Europe Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 45. Europe Rosuvastatin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 47. Europe Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Rosuvastatin Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Rosuvastatin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Rosuvastatin Sales byType (2020-2025) & (K MT)
Table 51. Middle East & Africa Rosuvastatin Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Rosuvastatin
Table 53. Key Market Challenges & Risks of Rosuvastatin
Table 54. Key IndustryTrends of Rosuvastatin
Table 55. Rosuvastatin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Rosuvastatin Distributors List
Table 58. Rosuvastatin Customer List
Table 59. Global Rosuvastatin SalesForecast by Region (2026-2031) & (K MT)
Table 60. Global Rosuvastatin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 62. Americas Rosuvastatin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Rosuvastatin SalesForecast by Region (2026-2031) & (K MT)
Table 64. APAC Rosuvastatin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 66. Europe Rosuvastatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Rosuvastatin SalesForecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Rosuvastatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Rosuvastatin SalesForecast byType (2026-2031) & (K MT)
Table 70. Global Rosuvastatin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Rosuvastatin SalesForecast by Application (2026-2031) & (K MT)
Table 72. Global Rosuvastatin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. AstraZeneca Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Rosuvastatin Product Portfolios and Specifications
Table 75. AstraZeneca Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78.Teva Pharmaceutical Industries Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 79.Teva Pharmaceutical Industries Rosuvastatin Product Portfolios and Specifications
Table 80.Teva Pharmaceutical Industries Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81.Teva Pharmaceutical Industries Main Business
Table 82.Teva Pharmaceutical Industries Latest Developments
Table 83. MSN Laboratories Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 84. MSN Laboratories Rosuvastatin Product Portfolios and Specifications
Table 85. MSN Laboratories Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. MSN Laboratories Main Business
Table 87. MSN Laboratories Latest Developments
Table 88. Cadila Pharmaceuticals Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Pharmaceuticals Rosuvastatin Product Portfolios and Specifications
Table 90. Cadila Pharmaceuticals Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Cadila Pharmaceuticals Main Business
Table 92. Cadila Pharmaceuticals Latest Developments
Table 93. LGM Pharma Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 94. LGM Pharma Rosuvastatin Product Portfolios and Specifications
Table 95. LGM Pharma Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. LGM Pharma Main Business
Table 97. LGM Pharma Latest Developments
Table 98. Bal Pharma Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 99. Bal Pharma Rosuvastatin Product Portfolios and Specifications
Table 100. Bal Pharma Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bal Pharma Main Business
Table 102. Bal Pharma Latest Developments
Table 103. Changzhou PharmaceuticalFactory Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 104. Changzhou PharmaceuticalFactory Rosuvastatin Product Portfolios and Specifications
Table 105. Changzhou PharmaceuticalFactory Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Changzhou PharmaceuticalFactory Main Business
Table 107. Changzhou PharmaceuticalFactory Latest Developments
Table 108. Jingxin Pharm Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 109. Jingxin Pharm Rosuvastatin Product Portfolios and Specifications
Table 110. Jingxin Pharm Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Jingxin Pharm Main Business
Table 112. Jingxin Pharm Latest Developments
Table 113. Zhejiang Hisun Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 115. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zhejiang Hisun Pharmaceutical Main Business
Table 117. Zhejiang Hisun Pharmaceutical Latest Developments
Table 118. HEC Pharm Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 119. HEC Pharm Rosuvastatin Product Portfolios and Specifications
Table 120. HEC Pharm Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. HEC Pharm Main Business
Table 122. HEC Pharm Latest Developments
Table 123. Lunan Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 124. Lunan Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 125. Lunan Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Lunan Pharmaceutical Main Business
Table 127. Lunan Pharmaceutical Latest Developments
Table 128. NanjingFrochemTech Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 129. NanjingFrochemTech Rosuvastatin Product Portfolios and Specifications
Table 130. NanjingFrochemTech Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. NanjingFrochemTech Main Business
Table 132. NanjingFrochemTech Latest Developments
Table 133. Lianyungang Runzhong Pharmaceutical Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 134. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolios and Specifications
Table 135. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Lianyungang Runzhong Pharmaceutical Main Business
Table 137. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 138. Shandong Bechem Chemicals Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Bechem Chemicals Rosuvastatin Product Portfolios and Specifications
Table 140. Shandong Bechem Chemicals Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Shandong Bechem Chemicals Main Business
Table 142. Shandong Bechem Chemicals Latest Developments
Table 143. CTX Life Sciences Basic Information, Rosuvastatin Manufacturing Base, Sales Area and Its Competitors
Table 144. CTX Life Sciences Rosuvastatin Product Portfolios and Specifications
Table 145. CTX Life Sciences Rosuvastatin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. CTX Life Sciences Main Business
Table 147. CTX Life Sciences Latest Developments
LIST OFFIGURES
Figure 1. Picture of Rosuvastatin
Figure 2. Rosuvastatin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rosuvastatin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Rosuvastatin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rosuvastatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rosuvastatin Sales Market Share by Country/Region (2024)
Figure 10. Rosuvastatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity 98.0%
Figure 12. Product Picture of Purity 99.0%
Figure 13. Product Picture of Other
Figure 14. Global Rosuvastatin Sales Market Share byType in 2025
Figure 15. Global Rosuvastatin Revenue Market Share byType (2020-2025)
Figure 16. Rosuvastatin Consumed inTablet
Figure 17. Global Rosuvastatin Market:Tablet (2020-2025) & (K MT)
Figure 18. Rosuvastatin Consumed in Capsule
Figure 19. Global Rosuvastatin Market: Capsule (2020-2025) & (K MT)
Figure 20. Rosuvastatin Consumed in Others
Figure 21. Global Rosuvastatin Market: Others (2020-2025) & (K MT)
Figure 22. Global Rosuvastatin Sale Market Share by Application (2024)
Figure 23. Global Rosuvastatin Revenue Market Share by Application in 2025
Figure 24. Rosuvastatin Sales by Company in 2025 (K MT)
Figure 25. Global Rosuvastatin Sales Market Share by Company in 2025
Figure 26. Rosuvastatin Revenue by Company in 2025 ($ millions)
Figure 27. Global Rosuvastatin Revenue Market Share by Company in 2025
Figure 28. Global Rosuvastatin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Rosuvastatin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Rosuvastatin Sales 2020-2025 (K MT)
Figure 31. Americas Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 32. APAC Rosuvastatin Sales 2020-2025 (K MT)
Figure 33. APAC Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 34. Europe Rosuvastatin Sales 2020-2025 (K MT)
Figure 35. Europe Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Rosuvastatin Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa Rosuvastatin Revenue 2020-2025 ($ millions)
Figure 38. Americas Rosuvastatin Sales Market Share by Country in 2025
Figure 39. Americas Rosuvastatin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Rosuvastatin Sales Market Share byType (2020-2025)
Figure 41. Americas Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 42. United States Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Rosuvastatin Sales Market Share by Region in 2025
Figure 47. APAC Rosuvastatin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Rosuvastatin Sales Market Share byType (2020-2025)
Figure 49. APAC Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 50. China Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Rosuvastatin Sales Market Share by Country in 2025
Figure 58. Europe Rosuvastatin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Rosuvastatin Sales Market Share byType (2020-2025)
Figure 60. Europe Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 61. Germany Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 62.France Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Rosuvastatin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Rosuvastatin Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Rosuvastatin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Rosuvastatin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Rosuvastatin in 2025
Figure 75. Manufacturing Process Analysis of Rosuvastatin
Figure 76. Industry Chain Structure of Rosuvastatin
Figure 77. Channels of Distribution
Figure 78. Global Rosuvastatin Sales MarketForecast by Region (2026-2031)
Figure 79. Global Rosuvastatin Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Rosuvastatin Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Rosuvastatin Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Rosuvastatin Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Rosuvastatin Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Mouse ELISA Kits Market Growth 2026-2032
US$ 3,660.00
February 2026
167 pages
Global Prescription Drugs Market Growth 2023-2029
US$ 3,660.00
February 2023
121 pages
Global Disposable Infusion Pumps Market Growth 2024-2030
US$ 3,660.00
December 2024
110 pages
Global Needle-Free Diabetes Care Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
93 pages
Global Polyester Artificial Blood Vessel Market Growth 2023-2029
US$ 3,660.00
March 2023
108 pages
